No Shock! Emergent BioSolutions To Revenue From Pandemic (Half 2)

In the first part, we discussed the troubling history of Emergent Biosolutions. In the second part we examine the future effects and what this means for you.

New biosolutions and pandemics

The company’s goal has always been to gain monopoly by meeting government demand for vaccines. As a result, the company has other vaccine monopolies like that Smallpox Vaccine License and an exclusive license for an opioid Overdose-reducing drug called Narcan during pandemics.

In 2018, the opioid crisis was the country’s biggest health concern. Emergent’s The crisis response was the acquisition of the only Narcan-producing company in the United States that has FDA approval. A dose of Narcan is currently $ 150. Emergent BioSolutions continues sue any company that wants to compete in the manufacture of a generic drug and cheaper version of Narcan.

What about COVID-19? How will Emergent benefit from the pandemic?

New COVID-19 partners

at the beginning of MarchEmergent has partnered with Novavax with the intention of developing a vaccine against the novel virus. CEPI (Bill Gates Coalition for Epidemic Preparedness) is currently supporting the development of the Novavax COVID vaccine. Emergent then extended its partnership with Novavax later in March. A week later, the company partnered with VaxArt, another candidate to develop the COVID vaccine.

The VaxArt vaccine is designed to be a oral vaccine with more significant benefits about the Novavax vaccine. Oral vaccines offer greater temperature stability, accessibility, coverage, and self-administration. In addition, Emergent will develop two currently experimental blood plasma treatments.

COVID Vaccine Rapid Growing Assets

The company has so far received $ 14.5 million for the development of these plasma treatments from the Biomedical Advanced Research and Development Authority (BARDA).

Emergent will also benefit from the development and manufacture of Johnson & Johnson’s promised one billion vaccine doses for use in pandemics worldwide. The latter contract is set at $ 135 million.

The mandatory vaccine controversies

It is evident that the novel virus has caused significant panic around the world. The federal government of the United States has therefore launched the Warp Speed ​​project to curb the rapidly spreading virus infections.

Operation Warp Speed ​​is the private and public partnership that aims to distribute 300 million COVID vaccines by 2021 Warp Speed ​​Project selects a different set of vaccine candidates. It will also provide the resources necessary to develop, test and manufacture a vaccine. The pharmaceutical industry therefore states that a COVID vaccine will be ready due to at least a year the recent unveiling of “Warp SpeedWhich has little to do with conventional thinking.

For example, all 50 US states have mandatory vaccination laws for rubella, measles, and polio. However, they also offer exceptions for some types of vaccine for religious, medical or philosophical reasons. Still, the nation has constitutional immunization laws that protect the health of the public.

However, given the dire effects of COVID-19, the government is inclined to enforce mandatory vaccination laws regardless of religion, philosophy, or medical reason. In addition, a group from the State Bar Association in New York is now calling for mandatory vaccination for all Americans. The group makes legal arguments to support their argument.

David Reischer, Esq., Attorney & CEO of Legal advice says the following about the requirement for a vaccine:

The urge to find a vaccine for COVID has been fraught with overreach by the government for those Americans who distrust the government and do not want to take the vaccine when it is offered. The idea of ​​compulsory vaccination against COVID is preparing for a populist fight against the borders of the government and its encroachment on individual freedom.

The Jacobson judgment

In 1905 the Supreme Court dealt with a similar issue of compulsory vaccinations. It was imposed by the government on smallpox in the Jacobson v. Massachusetts case. In this case, the court ruled that the legislature could impose a mandatory vaccine. This was due to the “police force” of state-protected public health and safety. The court stated that such regulations do not violate the 14th right to amend freedom. Why? because it is a restriction by which everyone is necessarily subject to the “greater common good”.

This decision has priority to this day. At the same time, the occasional harmful results of vaccinations go undetected. This is due to the impossibility of judging whether or not a particular person can be safely vaccinated. Whether the courts will extend the Jacobson ruling to include a mandatory vaccine against COVID is very likely. It remains to be seen whether the population will obediently comply.

In the light of the pandemic

For many of these drug companies, both pride and profit are at stake. Emergent BioSolutions is working again to stand out from the rest of the fold in the face of the pandemic. Its CEO, Robert Kramer, was quick to say that There was no guarantee of how quickly a vaccine could be developed. However, he notes that the ongoing collaboration with other pharmaceutical companies will help speed up the process.

Emergent BioSolutions has an additional sequence of tasks aimed at supporting the objectives of the Warp Speed ​​project. This will be done under the original agreement with BARDA. The stated aim is to use all skills, capacities and specialist knowledge. The project will support the government’s drive to accelerate the development and manufacture of the COVID-19 vaccine. This new assignment is worth approximately $ 628 million. In response to Emergent’s involvement in vaccine development, David Reischer is quick to point out that:

A large participation of the pharmaceutical industry in the creation of a vaccine that will be made compulsory on all citizens should be a concern of all. While this does not imply or imply that anything nefarious is afoot, it is objectively impossible for these mega-corporations with ties to special interests to fully disclose their various conflicts of interest.

About the consolidation of his class

A history of monopoly attainment, FDA issues, anthrax controversies and concerns, conflicts of interest, military human experimentation, legal issues, and the misuse of funds. Still, Emergent BioSolutions is preparing for success during the COVID pandemic.

The alliance with VaxArt and Novavax is intended to minimize the evidence of the company’s historic profit acts and increase new vaccine manufacturing opportunities. And without a doubt, Emergent BioSolutions will make millions of dollars during yet another major pandemic, the novel coronavirus pandemic.

Elton was first a general writer. But after having a problem with weight management, he became passionately interested in a healthy lifestyle. Now he trains 5 times a week, lives on keto and writes about health.

Comments are closed.